Clinical Trial

Cannabidiol Into Breastmilk

Study acronym: CBD-ALLT
Recruiting
View on ClinicalTrials.gov →
Summary
Really few data published to date on the passage of CBD into breast milk. The investigators known that 17.5 percent of the French human being between 18 and 34 years old consume CBD and among this, nearly half are women. None official French data to say how many French breastfeeding mothers consume CBD. CBD is a legal, psychoactive but not psychoaddictive substance. CBD's pharmacokinetic and pharmacodynamics make us fear that CBD could easily go through mother's milk. No published data available on possible effect in breast-fed child, not even on possible biological passage in breast-fed child. The aim of his study is to evaluate the passage of CBD in blood and milk at different moments of the breastfeeding (mothers) and its possible found in the infants'urine.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-09-05; most recent amendment 2026-01-29.
Status change: Not Yet Recruiting → Recruiting 2026-01-29
Trial Details
NCT Number NCT06589258
Lead Sponsor Centre Hospitalier Régional d'Orléans
Conditions Breast Feeding
Enrollment 60 participants
Start Date 2025-10-06
Primary Completion 2027-10 (estimated)
Study Completion 2028-10 (estimated)
Updated on ClinicalTrials.gov 2026-01-30